Sponsor:
Telix Pharmaceuticals (Innovations) Pty Limited
Code:
NCT05563272
Conditions
Cervical Cancer
Colorectal Cancer
Esophageal Cancer
Gastric Cancer
Glioblastoma Multiforme
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
89Zr-DFO-girentuximab
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations